Good News: Recently, according to the relevant requirements of “Interim Measures for Gradient Cultivation and Management of Green Factories (GXBJ [2024] No. 13)”, and “Interim Measures for Evaluation and Management of Green Factories in Anhui Province (WJXJN [2019] No. 98)”, the Anhui Provincial Department of Industry and Information Technology organized and carried out the 2024 Anhui Province Green Factory Evaluation. Through enterprise application, municipal recommendation, expert review, meeting review, and public announcement, 150 enterprises including NIO Automotive Technology (Anhui) Co., Ltd. were identified as Anhui Green Factories (2024), and the list was released as follows:
Anhui Poly Pharm. Co., Ltd. (hereinafter referred to as "Anhui Poly "), a wholly-owned subsidiary of Hainan Poly Pharm. Co., Ltd., was included in the list of Anhui Green Factories (2024).
According to the relevant requirements of“Interim Measures for the Gradient Cultivation and Management of Green Factories (GXBJ[2024] No. 13)”, “Interim Measures for the Evaluation and Management of Green Factories in Anhui Province (WJXJN[2019] No. 98)”, and “Notice of the Anhui Provincial Department of Industry and Information Technology on the Recommendation and Related Review of Provincial Green Factories in 2024”, after the application of enterprises, the review and recommendation of the industrial and information authorities in Anhui Province, the preliminary review and expert review of the Anhui Provincial Department of Industry and Information Technology, the Anhui Provincial Department of Industry and Information Technology intends to evaluate 150 enterprises such as Modern Animal Husbandry (Bengbu) Co., Ltd. as green factories in Anhui Province (2024), and publish the list:
Anhui Poly was included in the list of Anhui Green Factory (2024).
Established in 2019, Anhui Poly is a professional supplier of active raw materials, providing high-quality chemical synthetic and biosynthetic raw materials to the global pharmaceutical, health care and skin care fields.
Relying on strong research and development capabilities and technology transformation capabilities, the company has completed the commercial development, production and global registration of contrast agents (Gadoterate Meglumine, Gadoteridol, Gadobutrol, Iomeprol, Iopromide, Ioversol, Iopamidol, Iodixanol), synthetic biology ( ectoin, salidroside, Ursodeoxycholic acid), antitumor (cyclophosphamide), other API (Magnesium hydroxide, Apremilast, Crisaborole, Voriconazole, Memantine hydrochloride), and other pharmaceutical excipients (DOTA, SBE-β-CD, Calteridol calcium, Calcobutrol).
Anhui Poly adheres to the group tenet of "Good Medicine, Health People", implements the core values of "Integrity, Efficiency, Innovation and Expertise", and is committed to becoming a leader in the field of characteristic APIs.
The company always adheres to customer demand-oriented, quality-oriented, and uses leading technology to build an extraordinary road to international high-end API supplier.
Contact：Doctor Nie
18857693467
nieliangdeng@hnpoly.com
